The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
Launched by UNIVERSITY OF NEW HAMPSHIRE · Jun 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a lifestyle that promotes weight gain, known as an "obesogenic lifestyle," affects young adults who are usually physically active. The researchers want to find out if eating more carbohydrates while becoming less active makes it harder for the body to regulate blood sugar and increases insulin resistance, which can lead to health problems like obesity and diabetes. They also want to see if staying active can help balance how the body uses carbohydrates and fats, even when the diet changes.
To be eligible for the study, participants should be between 18 and 30 years old and regularly engage in moderate to vigorous exercise for at least 75 to 150 minutes a week. Those with certain health conditions, like high blood pressure or diabetes, cannot participate. If you join the study, you can expect to undergo some assessments to monitor your body’s response to lifestyle changes, and your involvement will help researchers understand the impacts of diet and activity levels on health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-30 years of age
- • Recreationally active completing 75-150 minutes of moderate-to-vigorous intensity exercise (\>2 days/week).
- • Fair cardiorespiratory fitness levels (Men: VO2\>38.4 ml/kg/min; Women: VO2\>32.6 ml/kg/min).
- Exclusion Criteria:
- • Hypertension (resting or diagnosed)
- • Impaired fasting blood glucose (\>100mg/dL)
- • Diagnosed cardiovascular disease
- • Diagnosed diabetes
- • Diagnosed cancer
- • Diagnosed chronic kidney disease
- • Diagnosed musculoskeletal disorders that prevents the individual from exercising on a bike.
About University Of New Hampshire
The University of New Hampshire (UNH) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UNH conducts a variety of studies aimed at addressing pressing health challenges. The university leverages its robust academic resources, state-of-the-art facilities, and a commitment to ethical research practices to ensure the integrity and reliability of its clinical investigations. By engaging with diverse populations and fostering partnerships with healthcare providers, UNH strives to translate research findings into tangible benefits for communities and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, New Hampshire, United States
Patients applied
Trial Officials
Michael S Brian, PhD
Principal Investigator
University of New Hampshire
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported